Clinical Trial Update: Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating CT071 injections in high-risk, newly diagnosed multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CT071

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING